D Concordet
Levothyrox® new and old formulations: are they switchable for millions of patients?
Concordet, D; Gandia, P; Montastruc, J L; Bousquet-Mélou, A; Lees, P; Ferran, A; Toutain, P L
Authors
P Gandia
J L Montastruc
A Bousquet-Mélou
P Lees
A Ferran
P L Toutain
Citation
Concordet, D., Gandia, P., Montastruc, J. L., Bousquet-Mélou, A., Lees, P., Ferran, A., & Toutain, P. L. (2019). Levothyrox® new and old formulations: are they switchable for millions of patients?. Clinical Pharmacokinetics, https://doi.org/10.1007/s40262-019-00747-3
Journal Article Type | Article |
---|---|
Acceptance Date | Feb 4, 2019 |
Publication Date | Apr 4, 2019 |
Deposit Date | Jan 25, 2019 |
Publicly Available Date | Nov 20, 2020 |
Journal | Clinical Pharmacokinetics |
Print ISSN | 0312-5963 |
Publisher | Adis |
Peer Reviewed | Peer Reviewed |
DOI | https://doi.org/10.1007/s40262-019-00747-3 |
Public URL | https://rvc-repository.worktribe.com/output/1382869 |
Files
11897.pdf
(572 Kb)
PDF
11897_pub.pdf
(756 Kb)
PDF
You might also like
Pharmacology, safety, efficacy and clinical uses of the COX?2 inhibitor robenacoxib
(2022)
Journal Article